Neuren Pharmaceuticals Limited (ASX: NEU)
Australia
· Delayed Price · Currency is AUD 12.36
-0.07 (-0.56%)
Nov 22, 2024, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 1.58 billion as of November 22, 2024. Its market cap has increased by 1.89% in one year.
Market Cap
1.58B
Enterprise Value
1.37B
Revenue
193.34M
Ranking
n/a
PE Ratio
13.82
Stock Price
12.36
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.58B, an increase of 7,449.26%. That is a compound annual growth rate of 24.40%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 132.82B |
| ResMed Inc. | 53.57B |
| Pro Medicus Limited | 22.43B |
| Fisher & Paykel Healthcare Corporation Limited | 19.67B |
| Cochlear Limited | 19.50B |
| Sonic Healthcare Limited | 13.34B |
| Ramsay Health Care Limited | 8.73B |
| Telix Pharmaceuticals Limited | 7.68B |